Skip to main content
. 2020 Apr 29;10:7271. doi: 10.1038/s41598-020-64235-6

Table 1.

Characteristics of patients with chronic obstructive pulmonary disease.

Variable All GOLD Group p Value
Group A(n = 36) Group B(n = 75) Group C(n = 7) Group D(n = 20)
Age in years 72 (37–91) 71 (37–87) 72 (54–85) 79 (65–82) 73 (56–87) 0.406
Male 131 (95) 32 (89) 73 (97) 6 (86) 20 (100) 0.099
Weight, kg 63 (40–102) 63.2 (43–87) 62.9 (40–102) 56 (49–71) 66 (52–81) 0.319
Height, cm 164 (146–180) 162 (147–180) 162.8 (146–180) 165 (158–170) 164.5 (158–172) 0.567
Body mass index, kg/m2 23.2 (16–36.1) 22.85 (19.4–29.1) 23.7 (16–36.1) 20.6 (19.1–21.6) 24 (19.3–28.6) 0.289
FEV1, L 1.46 (0.45–3.25) 1.79 (0.75–3.25) 1.35 (0.45–2.54) 1.46 (0.85–2.32) 1.36 (0.83–2.44) 0.009
FEV1, % predicted 71.8 (22.3–131.1) 80 (34.5–130.9) 69.2 (22.3–131.1) 75.7 (54.9–89.8) 63.6 (32.3–124.4) 0.014
Smoking status 0.576
Current smoker 28 (20) 10 (28) 14 (19) 1 (14) 3 (15)
Former smoker 74 (54) 18 (50) 44 (59) 3 (43) 9 (45)
Never smoker 19 (14) 3 (8) 10 (13) 2 (29) 4 (20)
mMRC dyspnea score <0.001
Grade 0 4 (3) 3 (8) 1 (1) 0 0
Grade 1 43 (31) 33 (92) 3 (4) 7 (100) 0
Grade 2 67 (49) 0 56 (75) 0 11 (55)
Grade 3 24 (17) 0 15 (20) 0 9 (45)
Grade 4 0 0 0 0 0
CAT score <0.001
≤10 106 (77) 36 (100) 51 (68) 7 (100) 12 (60)
11–20 29 (21) 0 23 (31) 0 6 (30)
21–30 3 (2) 0 1 (1) 0 2 (10)
31–40 0 0 0 0 0
Comorbidity
Cerebrovascular accident or neuromuscular disease 12 (9) 1 (3) 10 (13) 1 (14) 0 0.120
Head and neck tumor 5 (4) 2 (6) 3 (4) 0 0 0.698
Cardiovascular diseases 50 (36) 7 (19) 31 (41) 2 (29) 10 (50) 0.070
Asthma 13 (9) 2 (6) 7 (9) 1 (14) 3 (15) 0.670
Hypertension 65 (47) 13 (36) 40 (53) 0 12 (60) 0.015
Diabetes mellitus 36 (26) 8 (22) 17 (23) 0 4 (20) 0.566

Data presented as n (%) or median (range).

CAT, Chronic obstructive pulmonary disease assessment test; FEV1, forced expiratory volume in one second; GOLD: Global Initiative for Chronic Obstructive; mMRC, modified medical research council.